Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. - Wikidata - wikimedia - TriplyDB

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

http://www.wikidata.org/entity/Q37363568

about

Prognostic significance of volume-based PET parameters in cancer patients.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients Prognostic value of volume-based positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [(18)F] fluorodeoxyglucose posit Prognostic Significance of Standardized Uptake Value on 18Fluorine-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nasopharyngeal Carcinoma.Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.(18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer: A retrospective analysis.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer.

P2860

Q27687836-17C39985-0664-4E13-ABEE-6AC3C0B938E8 Q33669828-92A72BE7-3445-46CA-A631-4E334BDB9084 Q33704148-809566DA-2E12-4528-A1E1-8BE05C63C548 Q33704656-56F85598-35F2-4597-A8E8-DEA4C2CB1790 Q33819012-6374D339-FC38-45EE-83A8-EB3BAC8206B8 Q34234294-21C06408-4B75-4330-955A-A0A4D516CA81 Q34346395-7456908E-7202-4827-98A9-BCDFDA759BE9 Q34468661-69E4FFCD-64D5-421E-9DE0-1E8C4DCF0C29 Q34951384-C92218F2-496C-4582-82F8-D350CF63C46C Q34977651-75078EF8-B161-47ED-BBDD-50521D808CBB Q34998582-AA7BDABA-A02A-4A81-AF02-A237BC62793F Q35078927-9FD64894-D1AB-49FB-AB5E-1AD7B1454EDC Q35096212-D016CE8B-A2FF-45F5-9060-8B066ADFA95F Q35228288-011187ED-4426-44A9-8D57-3B78AA14EE25 Q35670356-5C8EBCB9-1C64-4103-A5C4-0B95F437842C Q35672382-50C50086-70DA-4CA2-904A-BB1DE0A3441A Q35789209-F240FE90-47A5-49ED-BD79-E518D69B5538 Q35871945-8BD29332-2984-4D6C-B026-280B544D0462 Q35916248-53C110A3-D4F6-458A-A50B-064FF500CC6B Q35916573-C31160CC-9FB6-4B35-8C72-0FCE448D1143 Q35961361-9B8543F6-85D5-45C4-8B9C-9FD4916DBBF4 Q36355220-AA0525F1-5BCF-488F-82DF-333CC69BDDDE Q36357282-97FF4DB7-D536-44FD-9A65-3F5CAA38B5E8 Q36619504-5E20F8E9-DBED-492D-B282-545F97D5A425 Q36655475-83C1D02E-650A-456F-BD8F-F66232F6D910 Q36681329-73B4CD91-B452-47F6-9F4D-64D0DA89185C Q37033505-840CCA94-A5F1-490B-B1C7-FFD18F126DCF Q37192658-98ADB783-AD97-4888-8D02-F5A1F3CC159A Q37649209-02EE8708-7D10-42E6-BBFD-5A316CA1E744 Q37653213-3C2A39B2-AF29-4594-8B3F-3CC3D2D3B7D1 Q38224477-DB9F1203-ACAA-443A-BD1C-8481FF9DF1E3 Q38249891-6ECE53E6-5737-412D-8CAA-5A9CBD3E74DA Q38410245-03C5F8E1-4FFD-48C8-AA11-A94932FF2866 Q38478344-A435008E-CD8A-43EF-90AC-591413926179 Q38704691-30DCC22F-F67E-47DB-8B20-15DC5D74371C Q38836743-55F34F45-7AF2-4797-8EB8-D935D14626A1 Q38896865-EB6F2CF4-E8EC-4CF6-9092-513F1D6BCF41 Q38909224-518F0AAE-6EF8-4947-BAE7-37D0DD58E7B1 Q40187157-3B453D1E-69F6-4295-9737-DDF1EF03B80C Q40539372-3030AEC7-03FB-4498-BA13-B5EA75096D84

P2860

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

http://www.wikidata.org/entity/Q37363568

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@en

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@nl

type

label

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@en

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@nl

prefLabel

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@en

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@nl

P1433

Q37363568-C852A8CA-F79D-4D11-84FD-E54DD68119AF

P1476

Q37363568-A061C7A6-00BE-4004-873E-1E9F73986760

P2093

Q37363568-116A98E9-D5A7-4BAE-B61F-4BD77A248104

Q37363568-3A96B726-E2E7-40FA-A3FA-47B18BA61165

Q37363568-4398D421-F1DB-44F8-BEB0-7289F5DF7498

Q37363568-470A0256-5811-46BA-B9A9-9D3BCD137923

Q37363568-5E4B4729-07FA-4CE5-BC27-F9E6BDB96483

Q37363568-9CB2E4A3-DB9D-45BE-9128-B33036A7DA06

Q37363568-A00A0C96-85FB-411D-BEFD-9C680B7F720C

Q37363568-B8CCCD7B-0913-4A04-83AA-3EF17B5C840C

Q37363568-C58F822B-75D8-4659-8378-42103C925A4D

Q37363568-DC6EA989-1DD2-49B7-8900-CF4A80F2D325

P2860

Q37363568-04D0ACA0-2BF5-4317-B63B-EF2BE913CEB2

Q37363568-14C4FA8A-5811-445C-A66B-4697B99E5046

Q37363568-17289810-1872-4F35-9034-7CA5CB1B3712

Q37363568-236D750E-57B8-484D-B91B-658E9318DEBA

Q37363568-393DCFFC-7D13-4A83-893F-1FD6927E4F00

Q37363568-3E285E23-D848-464E-BB15-226117BAFC08

Q37363568-82AA339A-CAFD-4C6E-AA22-E383D0D73AA9

Q37363568-926FE06B-AC94-45FC-AB48-BEF372852D5B

Q37363568-9738F751-42EB-4DE1-92E0-2193ACF3CF35

Q37363568-A74D983D-312B-41C8-BA92-DEECE1486932

P304

Q37363568-E8B9F8ED-2BCB-4854-85C1-5BB94205CC77

P31

Q37363568-8446F0C8-B694-4C62-B432-E4775879FB15

P356

Q37363568-FC1D5C73-1B95-4FF3-BE90-124D36F3B7D8

P407

Q37363568-6188210F-660A-4FFC-8D7A-A815E755F22D

P433

Q37363568-06D57BA2-6E66-4AB4-99ED-01C450A9ED71

P478

Q37363568-B1F6C684-37ED-4D37-8A2C-AD9EFCD30961

P577

Q37363568-E5B104A2-A6F8-47C7-8C04-0F8BC77D98CE

P5875

Q37363568-B83399D4-6E5C-4A78-BA2B-A0E8C993B53A

P698

Q37363568-170630CF-54CF-4DD6-8ECB-D0A3E330CD84

P932

Q37363568-234A80AC-55D3-4C62-AD06-F3CE5D4C9AF1

P356

J.IJROBP.2008.10.060

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

@en

P2093

Andy Quon

http://www.w3.org/2001/XMLSchema#string

Billy W Loo

http://www.w3.org/2001/XMLSchema#string

Brit B Turnbull

http://www.w3.org/2001/XMLSchema#string

Edith J Filion

http://www.w3.org/2001/XMLSchema#string

Edward E Graves

http://www.w3.org/2001/XMLSchema#string

Jackie N Chu

http://www.w3.org/2001/XMLSchema#string

Khoa Nguyen

http://www.w3.org/2001/XMLSchema#string

Percy Lee

http://www.w3.org/2001/XMLSchema#string

Peter Maxim

http://www.w3.org/2001/XMLSchema#string

Quynh-Thu Le

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

The impact of FDG PET on the management of occult primary head and neck tumours.

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.

2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx.

RT_Image: an open-source tool for investigating PET in radiation oncology.

Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year's experience in a clinical center.

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.

P304

1335-1341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2008.10.060

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24203668

http://www.w3.org/2001/XMLSchema#string

P698

19289263

http://www.w3.org/2001/XMLSchema#string

P932

2752334

http://www.w3.org/2001/XMLSchema#string